The peritoneal explant test for evaluating tissue tolerance to mouthrinses

Skin Pharmacology and Physiology

Volumn 20, Issue 3, 2007, Pages 162-166

  Welk, A ^a,b   Rosin, M ^a,c   Ludtke C ^a   Schwahn, C ^a   Kramer, A ^a   Daeschlein, G ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Amine stannous fluoride; Chlorhexidine; Essential oil; Mouthrinse; Peritoneal explant test; Tissue tolerance; Triclosan

Indexed keywords

CHLORHEXAMED; CHLORHEXIDINE; COLGATE TOTAL; ESSENTIAL OIL; LISTERINE; MERIDOL; RINGER SOLUTION; TRICLOSAN; UNCLASSIFIED DRUG;

ANALYSIS OF VARIANCE; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DRUG EFFECT; EXPLANT; MOUTH HYGIENE; NONHUMAN; PERITONEUM; PRIORITY JOURNAL; RAT; SENSITIVITY ANALYSIS; STATISTICAL SIGNIFICANCE; STUDENT T TEST; TISSUE INJURY;

AMINES; ANIMALS; ANIMALS, NEWBORN; ANTI-INFECTIVE AGENTS, LOCAL; CELL PROLIFERATION; CHLORHEXIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; MOUTHWASHES; ORGAN CULTURE TECHNIQUES; PERITONEUM; RATS; RATS, INBRED LEW; SALICYLATES; TERPENES; TIME FACTORS; TIN FLUORIDES; TOXICITY TESTS; TRICLOSAN;

EID: 34248994948     PISSN: 16605527     EISSN: None     Source Type: Journal    
DOI: 10.1159/000098703     Document Type: Article

References (38)

1. Association CoDTAH: Preventing bacterial endocarditis: a statement for the dental professional. J Am Dent Assoc 1991;122:87-92.
2. Macfarlane TW, Ferguson MM, Mulgrew CJ: Post-extraction bacteraemia: role of antiseptics and antibiotics. Br Dent J 1984;156:179-181.
3. Rahn R, Adamietz IA, Böttcher HD, Reimer K, Fleischer W: PVP-Iod-Lösung zur Mukositis-Prophylaxe bei therapeutischer Bestrahlung. Dtsch Z Mund Kiefer Gesichts Chir 1996;20:137-139.
4. Pitten FA, Kiefer T, Buth C, Doelken G, Kramer A: Do cancer patients with chemotherapy-induced leukopenia benefit from an antiseptic chlorhexidine-based oral rinse? A double-blind, block-randomized, controlled study. J Hosp Infect 2003;53:283-291.
5. DeRiso AJ 2nd, Ladowski JS, Dillon TA, Justice JW, Peterson AC: Chlorhexidine gluconate 0.12% oral rinse reduces the incidence of total nosocomial respiratory infection and nonprophylactic systemic antibiotic use in patients undergoing heart surgery. Chest 1996;109:1556-1561.
6. Brecx M, Netuschil L, Reichert B, Schreil G: Efficacy of Listerine, Meridol and chlorhexidine mouthrinses on plaque, gingivitis and plaque bacteria vitality. J Clin Periodontol 1990;17:292-297.
7. Brecx M: Strategies and agents in supragingival chemical plaque control. Periodontol 2000 1997;15:100-108.
8. Santos A: Evidence-based control of plaque and gingivitis. J Clin Periodontol 2003;30(suppl 5):13-16.
9. Rosin M, Welk A, Kocher T, Majic-Todt A, Kramer A, Pitten FA: The effect of a polyhexamethylene biguanide mouthrinse compared to an essential oil rinse and a chlorhexidine rinse on bacterial counts and 4-day plaque regrowth. J Clin Periodontol 2002;29:392-399.
10. Welk A, Splieth CH, Schmidt-Martens G, Schwahn C, Kocher T, Kramer A, et al: The effect of a polyhexamethylene biguanide mouthrinse compared with a triclosan rinse and a chlorhexidine rinse on bacterial counts and 4-day plaque re-growth. J Clin Periodontol 2005;32:499-505.
11. Quirynen M, Avontroodt P, Peeters W, Pauwels M, Coucke W, van Steenberghe D: Effect of different chlorhexidine formulations in mouthrinses on de novo plaque formation. J Clin Periodontol 2001;28:1127-1136.
12. Albandar JM, Gjermo P, Preus HR: Chlorhexidine use after two decades of over-thecounter availability. J Periodontol 1994;65:109-112.
13. European Committee for Standardization: EN 1040: Chemical Disinfectants and Antiseptics - Basic Bactericidal Activity - Test Method and Requirements (Phase 1). Brussels, European Committee for Standardization, 1997, confirmed 2002.
14. Pitten FA, Werner HP, Kramer A: A standardized test to assess the impact of different organic challenges on the antimicrobial activity of antiseptics. J Hosp Infect 2003;55:108-115.
15. Smulow JB, Glickman I: An epithelial-like cell line in continuous culture from normal adult human gingiva. Proc Soc Exp Biol Med 1966;121:1294-1296.
16. Zuckerbraun HL, Babich H, May R, Sinensky MC: Triclosan: cytotoxicity, mode of action, and induction of apoptosis in human gingival cells in vitro. Eur J Oral Sci 1998;106:628-636.
17. Kasten FH, Pineda LF, Schneider PE, Rawls HR, Foster TA: Biocompatibility testing of an experimental fluoride releasing resin using human gingival epithelial cells in vitro. In Vitro Cell Dev Biol 1989;25:57-62.
18. Mariotti AJ, Rumpf DA: Chlorhexidine-induced changes to human gingival fibroblast collagen and non-collagen protein production. J Periodontol 1999;70:1443-1448.
19. Dogan S, Gunay H, Leyhausen G, Geurtsen W: Effects of low-concentrated chlorhexidine on growth of Streptococcus sobrinus and primary human gingival fibroblasts. Clin Oral Investig 2003;7:212-216.
20. Kamata N, Fujimoto R, Tomonari M, Taki M, Nagayama M, Yasumoto S: Immortalization of human dental papilla, dental pulp, periodontal ligament cells and gingival fibroblasts by telomerase reverse transcriptase. J Oral Pathol Med 2004;33:417-423.
21. Babich H, Visioli F: In vitro cytotoxicity to human cells in culture of some phenolics from olive oil. Farmaco 2003;58:403-407.
22. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, et al: Extension of lifespan by introduction of telomerase into normal human cells. Science 1998;279:349-352.
23. Kramer A, Adrian V, Rudolph P, Wurster S, Lippert H: Explant test with skin and peritoneum of the neonatal rat as a predictive test of tolerance of local anti-infective agents in wounds and body cavities (in German). Chirurg 1998;69:840-845.
24. Mankodi S, Ross NM, Mostler K: Clinical efficacy of listerine in inhibiting and reducing plaque and experimental gingivitis. J Clin Periodontol 1987;14:285-288.
25. Lang NP, Hase JC, Grassi M, Hammerle CH, Weigel C, Kelty E, et al: Plaque formation and gingivitis after supervised mouthrinsing with 0.2% delmopinol hydrochloride, 0.2% chlorhexidine digluconate and placebo for 6 months. Oral Dis 1998;4:105-113.
26. Jenkins S, Addy M, Newcombe RG: Dose response of chlorhexidine against plaque and comparison with triclosan. J Clin Periodontol 1994;21:250-255.
27. Elworthy A, Greenman J, Doherty FM, Newcombe RG, Addy M: The substantivity of a number of oral hygiene products determined by the duration of effects on salivary bacteria. J Periodontol 1996;67:572-576.
28. Arweiler NB, Henning G, Reich E, Netuschil L: Effect of an amine-fluoride-triclosan mouthrinse on plaque regrowth and biofilm vitality. J Clin Periodontol 2002;29:358-363.
29. Gilbert RJ, Williams PE: The oral retention and antiplaque efficacy of triclosan in human volunteers. Br J Clin Pharmacol 1987;23:579-583.
30. Cummins D: Zinc citrate/Triclosan: a new anti-plaque system for the control of plaque and the prevention of gingivitis: short-term clinical and mode of action studies. J Clin Periodontol 1991;18:455-461.
31. Heath K, Singh V, Logan R, McIntyre J: Analysis of fluoride levels retained intraorally or ingested following routine clinical applications of topical fluoride products. Aust Dent J 2001;46:24-31.
32. Vivien-Castioni N, Gurny R, Baehni P, Kaltsatos V: Salivary fluoride concentrations following applications of bioadhesive tablets and mouthrinses. Eur J Pharm Biopharm 2000;49:27-33.
33. Gilbert RJ: The oral clearance of zinc and triclosan after delivery from a dentifrice. J Pharm Pharmacol 1987;39:480-483.
34. Lin YJ: Buccal absorption of triclosan following topical mouthrinse application. Am J Dent 2000;13:215-217.
35. Moss T, Howes D, Williams FM: Percutaneous penetration and dermal metabolism of triclosan (2,4, 4′-trichloro-2′-hydroxydiphenyl ether). Food Chem Toxicol 2000;38:361-370.
36. Wang LQ, Falany CN, James MO: Triclosan as a substrate and inhibitor of 3′-phosphoadenosine 5′-phosphosulfate-sulfotransferase and UDP-glucuronosyl transferase in human liver fractions. Drug Metab Dispos 2004;32:1162-1169.
37. Pitten FA, Kramer A: Antimicrobial efficacy of antiseptic mouthrinse solutions. Eur J Clin Pharmacol 1999;55:95-100.
38. Foote RL, Loprinzi CL, Frank AR, O'Fallon JR, Gulavita S, Tewfik HH, et al: Randomized trial of a chlorhexidine mouthwash for alleviation of radiation-induced mucositis. J Clin Oncol 1994;12:2630-2633.